Carcinoma, Thymic
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies (NCT01306045) | National Cancer Institute (NCI) | 2011-02-08 |
Track Carcinoma, Thymic automatically
Every clearance here is in the API, with alerts when new ones post.